Aortic valve replacement with biological prosthesis in patients aged 50-69 years.

Pietro Giorgio MalvindiSuvitesh LuthraCarlo OlevanoHamdy SalemMariusz Kowalewski Sunil K Ohri

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2021)

There was no difference in long-term survival between mechanical and biological prostheses for both age groups. Mechanical prostheses had a higher risk of bleeding in the 60-69-year group whereas biological valves had higher overall reintervention probability without an impact on long-term survival. It may be safe to use biological valves based on lifestyle choices for patients in the 50-69-year age group.

Keyphrases

aortic valve replacement
end stage renal disease
ejection fraction
aortic valve
chronic kidney disease
newly diagnosed
peritoneal dialysis
aortic stenosis
prognostic factors
cardiovascular disease
metabolic syndrome
physical activity
atrial fibrillation
type diabetes
heart failure
weight loss
patient reported